Use of an adenosine antagonist

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7088 (2006.01) A61K 31/4375 (2006.01) A61K 31/4418 (2006.01) A61K 31/519 (2006.01) A61K 31/522 (2006.01) A61K 31/7076 (2006.01) A61P 9/04 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2669166

Uses for a selective adenosine A3 receptor antagonist, or RNAi directed against said receptor, to treat myocardial infarction and heart conditions including heart failure, are provided. Optionally, an adenosine A2a receptor agonist may also be used with the adenosine A3 receptor antagonist. Methods of treating heart failure are also provided.

La présente invention concerne des utilisations d'un antagoniste sélectif du récepteur A3 de l'adénosine, ou d'ARNi dirigés contre ce récepteur, pour traiter l'infarctus du myocarde et des pathologies cardiaques telles que l'insuffisance cardiaque. Un agoniste du récepteur A2a de l'adénosine peut éventuellement aussi être utilisé conjointement à l'antagoniste du récepteur A3 de l'adénosine. Cette invention concerne également des méthodes de traitement de l'insuffisance cardiaque.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of an adenosine antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of an adenosine antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an adenosine antagonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1522523

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.